Aeovian Pharmaceuticals, Inc. — Form D

Aeovian Pharmaceuticals, Inc. of Berkeley, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-10-09. The offering totals $48.8M, of which $18.8M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (28)

Showing 25 of 28 people.

NameRoleLocation
Jens EcksteinDirectorCambridge, MA
Richard GasterDirectorWaltham, MA
Michael PowellDirectorCambridge, MA
Stelios TzannisDirectorWalnut Creek, CA
Stelios TzannisExecutive OfficerWalnut Creek, CA
Ben ZadikExecutive OfficerSan Francisco, CA
John J KincaidExecutive OfficerBerkeley, CA
Youssef J BennaniDirectorBerkeley, CA
Themasap J KhanDirectorBerkeley, CA
Nils J ReggeDirectorBerkeley, CA
Davis J RymanExecutive OfficerBerkeley, CA
William J GreeneDirectorBerkeley, CA
Micah J ZajicExecutive OfficerBerkeley, CA
Lars J EkmanDirectorBerkeley, CA
Justin J GoverDirectorBerkeley, CA
Allison J HulmeDirectorBerkeley, CA
Allison J HulmeExecutive OfficerBerkeley, CA
Richard J GasterDirectorBerkeley, CA
David LoweDirectorWalnut Creek, CA
James PeyerDirectorNew York, NY
Davis C RymanExecutive OfficerBerkeley, CA
Nils C ReggeDirectorBerkeley, CA
Matthew J PlunkettExecutive OfficerBerkeley, CA
William C GreeneDirectorBerkeley, CA
John F KincaidExecutive OfficerBerkeley, CA

Other filings by this issuer (3)

FiledFormOfferingSold
2025-12-22D$55.0M$55.0M
2024-05-13D$50.4M$50.4M
2017-06-28D$3.8M$786K

More